Opportunity Information: Apply for PAR 19 228
The Institutional Translational Research Training Program (T32) is a National Institutes of Health (NIH) training grant run through the National Institute of Neurological Disorders and Stroke (NINDS). Its main goal is to train the next generation of neuroscience researchers to move beyond basic discovery and understand what it takes to turn lab findings into real clinical applications. In practice, the program is designed to help trainees bridge the gap between fundamental, disease-relevant research and the steps required to develop viable therapies, devices, diagnostics, or other interventions that can ultimately benefit patients.
A core feature of this opportunity is the training environment it expects institutions to provide. Funded programs must place trainees in settings where basic neuroscientists and clinicians work together in active, collaborative research efforts, so trainees routinely see how clinical realities shape research questions and how mechanistic findings can be positioned for human use. In addition, programs must include researchers who specifically have translational expertise and are already doing work intended to push discoveries toward application rather than stopping at proof-of-concept. The program also emphasizes building connections outside academia, particularly relationships with industry partners and with government regulatory agencies, reflecting the reality that translation often requires understanding commercialization pathways, regulatory expectations, and development milestones.
The educational structure is expected to be cohesive and intentionally focused on translational research as a process, not just a topic area. Trainees should learn the stages, decision points, and practical constraints involved in translation while working on their own projects, so that training is integrated with real research execution. NINDS expects programs to cover skills that are essential for rigor and reproducibility, including strong experimental design and a thorough grounding in statistics and analytical methods. Communication training is also required, with an emphasis on communicating science effectively to different audiences, which can include interdisciplinary scientific teams, clinicians, industry stakeholders, regulators, and the broader public.
The typical training period is intended to be about two years, and the program can support one or more trainee groups: advanced predoctoral students, postdoctoral fellows, and fellowship-stage clinicians. By the end of the program, participants should be able to approach basic research problems with a clear understanding of downstream translational requirements, meaning they are better prepared to design studies and generate evidence that can support later development steps rather than producing findings that are difficult to advance toward patient impact.
Eligibility is broad and includes many types of U.S.-based organizations and government entities, such as public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), state and local governments, tribal governments (federally recognized), tribal organizations (including those other than federally recognized tribal governments), public housing authorities/Indian housing authorities, for-profit organizations (other than small businesses), and small businesses. The announcement also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components as defined by the NIH Grants Policy Statement may be allowed.
The opportunity is listed as a discretionary NIH grant program under Funding Opportunity Number PAR-19-228, with health-related activity and CFDA numbers 93.853 and 93.866. The original posting was created on March 22, 2019, and the original closing date listed is May 26, 2021. The notice does not specify an award ceiling or the expected number of awards in the provided source details, so applicants typically would need to consult the full FOA and NIH budget guidance for allowable costs, trainee slots, and programmatic expectations tied to T32 mechanisms.Apply for PAR 19 228
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Institutional Translational Research Training Program (T32)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
- This funding opportunity was created on 2019-03-22.
- Applicants must submit their applications by 2021-05-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
Previous opportunity: Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 228
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 228) also looked into and applied for these:
| Funding Opportunity |
|---|
| AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01) Apply for RFA HS 19 003 Funding Number: RFA HS 19 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed) Apply for PAR 19 229 Funding Number: PAR 19 229 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Preventive Health and Health Services Block Grant– 2019 Apply for CDC RFA OT19 1902 Funding Number: CDC RFA OT19 1902 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Development of Sample Sparing Assays for Monitoring Immune Responses (U24 Clinical Trial Not Allowed) Apply for RFA AI 19 017 Funding Number: RFA AI 19 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required) Apply for PA 19 230 Funding Number: PA 19 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 19 231 Funding Number: PAR 19 231 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 19 007 Funding Number: RFA RM 19 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 19 008 Funding Number: RFA RM 19 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional) Apply for RFA AI 19 036 Funding Number: RFA AI 19 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) Apply for PAR 19 232 Funding Number: PAR 19 232 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed) Apply for RFA AI 19 037 Funding Number: RFA AI 19 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) Apply for PAR 19 236 Funding Number: PAR 19 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) Apply for PAR 19 235 Funding Number: PAR 19 235 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed) Apply for PAR 19 234 Funding Number: PAR 19 234 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) Apply for PA 19 237 Funding Number: PA 19 237 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed) Apply for PAR 19 239 Funding Number: PAR 19 239 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed) Apply for PAR 19 240 Funding Number: PAR 19 240 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA HL 20 014 Funding Number: RFA HL 20 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18 Independent Clinical Trial Not Allowed) Apply for PAR 19 238 Funding Number: PAR 19 238 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 19 006 Funding Number: RFA RM 19 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 228", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
